Quarterly report · Q2
9438.TEDINET S100SBOM
Period2022-10-01 → 2023-03-31
Filed2023-11-20
StandardJapan GAAP
ConsolidatedYes
Data checks14 of 14 passed
Amends S100QQRZ.
Key figures · 47
| Metric | Value | Period | Scope | Source row |
|---|---|---|---|---|
| Revenue | ¥13.6bn | 2022-10-01 → 2023-03-31 | Cons. | Net sales |
| Revenue | ¥26.5bn | 2021-10-01 → 2022-09-30 | Cons. | Net sales (5-year summary) |
| Revenue | ¥13.0bn | 2021-10-01 → 2022-03-31 | Cons. | Net sales |
| Operating income | −¥19m | 2022-10-01 → 2023-03-31 | Cons. | Operating income |
| Operating income | ¥599m | 2021-10-01 → 2022-03-31 | Cons. | Operating income |
| Ordinary income | ¥187m | 2022-10-01 → 2023-03-31 | Cons. | Ordinary income |
| Ordinary income | ¥486m | 2021-10-01 → 2022-09-30 | Cons. | Ordinary income loss (5-year summary) |
| Ordinary income | ¥293m | 2021-10-01 → 2022-03-31 | Cons. | Ordinary income |
| Profit before tax | ¥291m | 2022-10-01 → 2023-03-31 | Cons. | Income before income taxes |
| Profit before tax | ¥363m | 2021-10-01 → 2022-03-31 | Cons. | Income before income taxes |
| Net income (owners) | −¥326m | 2022-10-01 → 2023-03-31 | Cons. | Profit loss attributable to owners of parent |
| Net income (owners) | −¥930m | 2021-10-01 → 2022-09-30 | Cons. | Profit loss attributable to owners of parent (5-year summary) |
| Net income (owners) | ¥123m | 2021-10-01 → 2022-03-31 | Cons. | Profit loss attributable to owners of parent |
| Net income | −¥401m | 2022-10-01 → 2023-03-31 | Cons. | Profit loss |
| Net income | ¥4m | 2021-10-01 → 2022-03-31 | Cons. | Profit loss |
| Total assets | ¥28.9bn | at 2023-03-31 | Cons. | Assets |
| Total assets | ¥29.3bn | at 2022-09-30 | Cons. | Assets |
| Total assets | ¥29.2bn | at 2022-03-31 | Cons. | Total assets (5-year summary) |
| Total liabilities | ¥11.8bn | at 2023-03-31 | Cons. | Liabilities |
| Total liabilities | ¥11.4bn | at 2022-09-30 | Cons. | Liabilities |
| Net assets / equity | ¥17.1bn | at 2023-03-31 | Cons. | Net assets |
| Net assets / equity | ¥17.9bn | at 2022-09-30 | Cons. | Net assets |
| Net assets / equity | ¥19.2bn | at 2022-03-31 | Cons. | Net assets (5-year summary) |
| Cash and deposits | ¥12.8bn | at 2023-03-31 | Cons. | Cash and deposits |
| Cash and deposits | ¥12.1bn | at 2022-09-30 | Cons. | Cash and deposits |
| Cash & equivalents | ¥12.8bn | at 2023-03-31 | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥12.1bn | at 2022-09-30 | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥12.6bn | at 2022-03-31 | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥15.5bn | at 2021-09-30d | Cons. | Cash and cash equivalents |
| Operating cash flow | ¥2.1bn | 2022-10-01 → 2023-03-31 | Cons. | Net cash provided by used in operating activities |
| Operating cash flow | −¥1.4bn | 2021-10-01 → 2022-09-30 | Cons. | Net cash provided by used in operating activities (5-year summary) |
| Operating cash flow | −¥788m | 2021-10-01 → 2022-03-31 | Cons. | Net cash provided by used in operating activities |
| Investing cash flow | −¥616m | 2022-10-01 → 2023-03-31 | Cons. | Net cash provided by used in investment activities |
| Investing cash flow | −¥2.5bn | 2021-10-01 → 2022-09-30 | Cons. | Net cash provided by used in investing activities (5-year summary) |
| Investing cash flow | −¥1.4bn | 2021-10-01 → 2022-03-31 | Cons. | Net cash provided by used in investment activities |
| Financing cash flow | −¥798m | 2022-10-01 → 2023-03-31 | Cons. | Net cash provided by used in financing activities |
| Financing cash flow | ¥344m | 2021-10-01 → 2022-09-30 | Cons. | Net cash provided by used in financing activities (5-year summary) |
| Financing cash flow | −¥776m | 2021-10-01 → 2022-03-31 | Cons. | Net cash provided by used in financing activities |
| EPS (basic) | ¥-5.95 | 2022-10-01 → 2023-03-31 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥4.82 | 2023-01-01 → 2023-03-31d | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥-16.99 | 2021-10-01 → 2022-09-30 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥2.25 | 2021-10-01 → 2022-03-31 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥-2.36 | 2022-01-01 → 2022-03-31d | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (diluted) | ¥2.25 | 2021-10-01 → 2022-03-31 | Cons. | Diluted earnings per share (5-year summary) |
| Equity ratio | 46.2% | at 2023-03-31 | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 48.1% | at 2022-09-30 | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 52.9% | at 2022-03-31 | Cons. | Equity to asset ratio (5-year summary) |
Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.
Segments · 44
| Segment | Item | Period | Value |
|---|---|---|---|
| Reconciling Itemsreconciling | revenue | 2022-10-01 → 2023-03-31 | −¥793m |
| Reconciling Itemsreconciling | revenue intersegment | 2022-10-01 → 2023-03-31 | −¥793m |
| Reconciling Itemsreconciling | segment profit | 2022-10-01 → 2023-03-31 | −¥1.3bn |
| jpcrp040300-q2r_E05049-000Content Businessreportable segment | revenue | 2022-10-01 → 2023-03-31 | ¥9.5bn |
| jpcrp040300-q2r_E05049-000Content Businessreportable segment | revenue external | 2022-10-01 → 2023-03-31 | ¥9.4bn |
| jpcrp040300-q2r_E05049-000Content Businessreportable segment | revenue intersegment | 2022-10-01 → 2023-03-31 | ¥89m |
| jpcrp040300-q2r_E05049-000Content Businessreportable segment | segment profit | 2022-10-01 → 2023-03-31 | ¥2.8bn |
| jpcrp040300-q2r_E05049-000Healthcare Businessreportable segment | revenue | 2022-10-01 → 2023-03-31 | ¥2.2bn |
| jpcrp040300-q2r_E05049-000Healthcare Businessreportable segment | revenue external | 2022-10-01 → 2023-03-31 | ¥2.2bn |
| jpcrp040300-q2r_E05049-000Healthcare Businessreportable segment | revenue intersegment | 2022-10-01 → 2023-03-31 | ¥5m |
| jpcrp040300-q2r_E05049-000Healthcare Businessreportable segment | segment profit | 2022-10-01 → 2023-03-31 | −¥220m |
| jpcrp040300-q2r_E05049-000Other Businessreportable segment | revenue | 2022-10-01 → 2023-03-31 | ¥2.4bn |
| jpcrp040300-q2r_E05049-000Other Businessreportable segment | revenue external | 2022-10-01 → 2023-03-31 | ¥1.7bn |
| jpcrp040300-q2r_E05049-000Other Businessreportable segment | revenue intersegment | 2022-10-01 → 2023-03-31 | ¥699m |
| jpcrp040300-q2r_E05049-000Other Businessreportable segment | segment profit | 2022-10-01 → 2023-03-31 | −¥807m |
| jpcrp040300-q2r_E05049-000School DX Businessreportable segment | revenue | 2022-10-01 → 2023-03-31 | ¥309m |
| jpcrp040300-q2r_E05049-000School DX Businessreportable segment | revenue external | 2022-10-01 → 2023-03-31 | ¥309m |
| jpcrp040300-q2r_E05049-000School DX Businessreportable segment | segment profit | 2022-10-01 → 2023-03-31 | −¥461m |
| —segment total | revenue | 2022-10-01 → 2023-03-31 | ¥14.4bn |
| —segment total | revenue external | 2022-10-01 → 2023-03-31 | ¥13.6bn |
| —segment total | revenue intersegment | 2022-10-01 → 2023-03-31 | ¥793m |
| —segment total | segment profit | 2022-10-01 → 2023-03-31 | ¥1.3bn |
| Reconciling Itemsreconciling | revenue | 2021-10-01 → 2022-03-31 | −¥646m |
| Reconciling Itemsreconciling | revenue intersegment | 2021-10-01 → 2022-03-31 | −¥646m |
| Reconciling Itemsreconciling | segment profit | 2021-10-01 → 2022-03-31 | −¥1.2bn |
| jpcrp040300-q2r_E05049-000Content Businessreportable segment | revenue | 2021-10-01 → 2022-03-31 | ¥9.1bn |
| jpcrp040300-q2r_E05049-000Content Businessreportable segment | revenue external | 2021-10-01 → 2022-03-31 | ¥9.0bn |
| jpcrp040300-q2r_E05049-000Content Businessreportable segment | revenue intersegment | 2021-10-01 → 2022-03-31 | ¥112m |
| jpcrp040300-q2r_E05049-000Content Businessreportable segment | segment profit | 2021-10-01 → 2022-03-31 | ¥2.9bn |
| jpcrp040300-q2r_E05049-000Healthcare Businessreportable segment | revenue | 2021-10-01 → 2022-03-31 | ¥1.9bn |
| jpcrp040300-q2r_E05049-000Healthcare Businessreportable segment | revenue external | 2021-10-01 → 2022-03-31 | ¥1.9bn |
| jpcrp040300-q2r_E05049-000Healthcare Businessreportable segment | revenue intersegment | 2021-10-01 → 2022-03-31 | ¥10m |
| jpcrp040300-q2r_E05049-000Healthcare Businessreportable segment | segment profit | 2021-10-01 → 2022-03-31 | −¥649m |
| jpcrp040300-q2r_E05049-000Other Businessreportable segment | revenue | 2021-10-01 → 2022-03-31 | ¥2.5bn |
| jpcrp040300-q2r_E05049-000Other Businessreportable segment | revenue external | 2021-10-01 → 2022-03-31 | ¥2.0bn |
| jpcrp040300-q2r_E05049-000Other Businessreportable segment | revenue intersegment | 2021-10-01 → 2022-03-31 | ¥524m |
| jpcrp040300-q2r_E05049-000Other Businessreportable segment | segment profit | 2021-10-01 → 2022-03-31 | −¥176m |
| jpcrp040300-q2r_E05049-000School DX Businessreportable segment | revenue | 2021-10-01 → 2022-03-31 | ¥121m |
| jpcrp040300-q2r_E05049-000School DX Businessreportable segment | revenue external | 2021-10-01 → 2022-03-31 | ¥121m |
| jpcrp040300-q2r_E05049-000School DX Businessreportable segment | segment profit | 2021-10-01 → 2022-03-31 | −¥233m |
| —segment total | revenue | 2021-10-01 → 2022-03-31 | ¥13.6bn |
| —segment total | revenue external | 2021-10-01 → 2022-03-31 | ¥13.0bn |
| —segment total | revenue intersegment | 2021-10-01 → 2022-03-31 | ¥646m |
| —segment total | segment profit | 2021-10-01 → 2022-03-31 | ¥1.8bn |
Segment names come from EDINET member IDs; not yet mapped to a common taxonomy.
All source rows · 540
| Item | Context | Value | Unit |
|---|---|---|---|
| Purchase of treasury stock of subsidiaries in consolidation fin cf | CurrentYTDDuration | - | JPY |
| Net cash provided by used in financing activities | Prior1YTDDuration | -776489000 | JPY |
| Net cash provided by used in financing activities | CurrentYTDDuration | -798208000 | JPY |
| Effect of exchange rate change on cash and cash equivalents | Prior1YTDDuration | 29113000 | JPY |
| Effect of exchange rate change on cash and cash equivalents | CurrentYTDDuration | -25385000 | JPY |
| Net increase decrease in cash and cash equivalents | Prior1YTDDuration | -2949381000 | JPY |
| Net increase decrease in cash and cash equivalents | CurrentYTDDuration | 665988000 | JPY |
| Cash and cash equivalents | Prior2YearInstant | 15540084000 | JPY |
| Cash and cash equivalents | Prior1YearInstant | 12097658000 | JPY |
| Cash and cash equivalents | Prior1QuarterInstant | 12590702000 | JPY |
| Cash and cash equivalents | CurrentQuarterInstant | 12763647000 | JPY |
| Advertising expenses sga | Prior1YTDDuration | 758009000 | JPY |
| Advertising expenses sga | CurrentYTDDuration | 1016659000 | JPY |
| Salaries and allowances sga | Prior1YTDDuration | 2955548000 | JPY |
| Salaries and allowances sga | CurrentYTDDuration | 3039964000 | JPY |
| Commission fee sga | Prior1YTDDuration | 1538433000 | JPY |
| Commission fee sga | CurrentYTDDuration | 1491871000 | JPY |
| Subcontract expenses sga | Prior1YTDDuration | 885607000 | JPY |
| Subcontract expenses sga | CurrentYTDDuration | 1059056000 | JPY |
| Depreciation sga | Prior1YTDDuration | 633504000 | JPY |
| Depreciation sga | CurrentYTDDuration | 591107000 | JPY |
| Revenues from external customers | Prior1YTDDuration_jpcrp040300-q2r_E05049-000ContentBusinessReportableSegmentMember | 8963659000 | JPY |
| Revenues from external customers | Prior1YTDDuration_jpcrp040300-q2r_E05049-000HealthcareBusinessReportableSegmentMember | 1875890000 | JPY |
| Revenues from external customers | Prior1YTDDuration_jpcrp040300-q2r_E05049-000SchoolDXBusinessReportableSegmentMember | 121247000 | JPY |
| Revenues from external customers | Prior1YTDDuration_jpcrp040300-q2r_E05049-000OtherBusinessReportableSegmentMember | 2014750000 | JPY |
| Revenues from external customers | Prior1YTDDuration_ReportableSegmentsMember | 12975547000 | JPY |
| Revenues from external customers | Prior1YTDDuration_ReconcilingItemsMember | - | JPY |
| Revenues from external customers | Prior1YTDDuration | 12975547000 | JPY |
| Transactions with other segments | Prior1YTDDuration_jpcrp040300-q2r_E05049-000ContentBusinessReportableSegmentMember | 112459000 | JPY |
| Transactions with other segments | Prior1YTDDuration_jpcrp040300-q2r_E05049-000HealthcareBusinessReportableSegmentMember | 9571000 | JPY |
| Transactions with other segments | Prior1YTDDuration_jpcrp040300-q2r_E05049-000SchoolDXBusinessReportableSegmentMember | - | JPY |
| Transactions with other segments | Prior1YTDDuration_jpcrp040300-q2r_E05049-000OtherBusinessReportableSegmentMember | 523974000 | JPY |
| Transactions with other segments | Prior1YTDDuration_ReportableSegmentsMember | 646005000 | JPY |
| Transactions with other segments | Prior1YTDDuration_ReconcilingItemsMember | -646005000 | JPY |
| Transactions with other segments | Prior1YTDDuration | - | JPY |
| Net sales | Prior1YTDDuration_jpcrp040300-q2r_E05049-000ContentBusinessReportableSegmentMember | 9076118000 | JPY |
| Net sales | Prior1YTDDuration_jpcrp040300-q2r_E05049-000HealthcareBusinessReportableSegmentMember | 1885461000 | JPY |
| Net sales | Prior1YTDDuration_jpcrp040300-q2r_E05049-000SchoolDXBusinessReportableSegmentMember | 121247000 | JPY |
| Net sales | Prior1YTDDuration_jpcrp040300-q2r_E05049-000OtherBusinessReportableSegmentMember | 2538724000 | JPY |
| Net sales | Prior1YTDDuration_ReportableSegmentsMember | 13621552000 | JPY |
| Net sales | Prior1YTDDuration_ReconcilingItemsMember | -646005000 | JPY |
| Net sales | Prior1YTDDuration | 12975547000 | JPY |
| Operating income | Prior1YTDDuration_jpcrp040300-q2r_E05049-000ContentBusinessReportableSegmentMember | 2857409000 | JPY |
| Operating income | Prior1YTDDuration_jpcrp040300-q2r_E05049-000HealthcareBusinessReportableSegmentMember | -648681000 | JPY |
| Operating income | Prior1YTDDuration_jpcrp040300-q2r_E05049-000SchoolDXBusinessReportableSegmentMember | -232956000 | JPY |
| Operating income | Prior1YTDDuration_jpcrp040300-q2r_E05049-000OtherBusinessReportableSegmentMember | -176321000 | JPY |
| Operating income | Prior1YTDDuration_ReportableSegmentsMember | 1799449000 | JPY |
| Operating income | Prior1YTDDuration_ReconcilingItemsMember | -1200235000 | JPY |
| Operating income | Prior1YTDDuration | 599214000 | JPY |
| Revenues from external customers | CurrentYTDDuration_jpcrp040300-q2r_E05049-000ContentBusinessReportableSegmentMember | 9413703000 | JPY |
Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.
Data checks · 14 of 14 passed
| balance sheet identity | pass |
| balance sheet identity | pass |
| dei present | pass |
| period resolution | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · operating cash flow | pass |
| statement vs summary · operating cash flow | pass |
| statement vs summary · revenue | pass |
| statement vs summary · revenue | pass |
| statement vs summary · total assets | pass |
| statement vs summary · total assets | pass |